Jasper Therapeutics has completed its all‑stock acquisition of Kira Pharmaceuticals, creating a combined business focused on ...

Ardena has appointed Ariane de Ganck as Chief Scientific Officer, reinforcing its focus on scientific excellence across its ...

Compass Pathways has announced six‑month results from its second phase 3 trial of COMP360, its synthetic formulation of ...

The Scottish Medicines Consortium has recommended Astellas’s VEOZA (fezolinetant) 45 mg once daily for the treatment of ...

EpilepsyGTx has partnered with ClearPoint Neuro to enable targeted delivery of its lead gene therapy candidate, EPY201, ahead ...

Grünenthal has received Orphan Drug and Rare Pediatric Disease designations from the US Food and Drug Administration for ...

An update on the first clinical trial evaluating a pluripotent stem cell‑derived neural stem cell therapy for Huntington’s ...

Braun has appointed Sophie Spencer as Social Value & ESG Specialist, recognising her rapid impact since joining the company ...

Merck has announced that the European Commission has approved an update to the Erbitux (cetuximab) EU label, extending its ...

Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics licence application for a once weekly subcutaneous initiation dose ...

Bayer has welcomed final draft guidance from NICE recommending finerenone for adults in England and Wales with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or ...

The UK’s ageing population is reshaping healthcare demand in largely predictable and preventable ways. Nearly one in five ...